Thursday, October 10, 2013

Microbial Improvements in Agriculture

 By Asta Stojanovski
(Image Source)

With the global population growing and increasing urbanization of the population, production of an adequate amount of food is becoming a major agricultural concern.  Increasing food production and productivity of crops is therefore of great importance to the industry. However, it is well known that currently used agricultural methods have a plethora of negative environmental consequences. Therefore one of the major challenges currently facing the industry is enhancing the productivity of food crops while mitigating the environmental impacts.

Scientists think this can be achieved by utilizing microbial communities in place of fertilizers and pesticides.  According to a new report by the American Academy of Microbiology titled “How Microbes Can Help Feed the World” there are plenty of development possibilities that could be capitalized on to use microbe-plant interactions to improve crop yields across the globe.   The report describes the scientific challenges currently faced, failures of biocontrol in the past, and new avenues that are currently being pursued.  It also provides recommendations for translating research into practical applications which is where most developments in the field of plant biotechnology are lost. 

(Rhizobium)
In addition to this report, there have been many other developments that could provide crop improvements by taking advantage of various microbial species. While it has long been known that the rhizobia bacteria inhabit and provide usable nitrogen to legume plants, it was not until recently that the mechanism of nutrient exchange or the precise interaction between microbes and plant were described.  Recent research at the MU Bond Life Sciences Center have elucidated the interaction-response relationship that allows rhizobia to form symbiotic relationships with legume crops but not others and are currently working on transferring the trait to other crop plants, such as corn. 

Rebecca Bell observing tomatoes in FDA lab
Additionally, researchers from the FDA’s “Team Tomato,” recently described characterization of a soil bacterium, Paenibacillus, which is harmless to humans but lethal to Salmonella that could be utilized in place of fumigants to reduce risk of salmonella outbreaks. Currently the FDA and the EPA are working together to develop an organic treatment using paenibacillus.  Arbuscular mycorrhizal fungi (AMF) have also been identified as an important microbe for the production of Cassava plants in the tropics. It has been shown by researchers in Columbia that Cassava inoculated in vitro with a mass produced mycorrrhizal fungus, Rhizophagus irregularis, has much higher yields of dry biomass compared to plants treated with traditional phosphate fertilizers.  These discoveries offer clear directions for the manipulation of microbes and soil constituents to crops advantage and will undoubtedly provide improved yields without requiring heavy use of chemicals.

It is important however to remember that these plant-microbe interactions do not occur in an isolated environment and that the whole micro-ecosystem must be taken into consideration to prevent disruptions in its functioning. Improvements in understanding the microbiome will undoubtedly lead to more discoveries with wide implications, for both agriculture and beyond.  Additionally, it can be very difficult to transform scientific discovery and knowledge into a practical application with commercial relevance. This will be one of the key challenges for these developments as time progresses. While there are still a number of hurdles to be overcome before these discoveries are rendered commercially available and implemented on a large scale, the advances in the field hold promise for improved agricultural production without sacrificing environmental health. 

Wednesday, September 25, 2013

Trends in Innovation for Biotechnology

By Asta Stojanovski

One of the key drivers behind innovation in biotechnology remains to be technological advancements and increases in computer processing power.  As these continue to advance, new developments in biotechnology will follow close behind providing a wider range of applications and improved functionality.  Here we review the top trends in biotechnology innovation in recent years and the future. 

Mobile Healthcare, Remote Monitoring & Point of Care Diagnostics

(Scout Physical Exam Scanner)
The proliferation of mobile devices in the last decade has provided us the opportunities to have our devices with us at all times and stay connected no matter where we are.  This has given rise to the idea of utilizing these devices for health monitoring, health data collection and provision of health services.  A large number of applications have been developed to be used for accessing healthcare or reporting health conditions during monitoring through our mobile devices, whether they are cell phones or personal computers, and these numbers are continuing to grow.  There is however current contention on how these devices should be regulated by the FDA. The continued trend towards miniaturization of devices has allowed for the development of new medical products that can conduct exams and perform monitoring without a visit to the doctor’s office, such as the Scanadu Scout or the Metria Wearable Sensor. This has significant applications for the elderly and disabled.

(LabChip Systems SipperChip)
The miniaturization of technology has also allowed for the development of point of care diagnostics that are can deliver immediate results outside of a laboratory setting.  This improves diagnosis times and allows diagnosis to be performed with minimal specialized infrastructure, at the patient’s home or in their hospital room. Additionally this can be beneficial in places without good laboratory foundation or in emergency situations.  There have also been developments in lab-on-a-chip platforms that allow for one or several laboratory tests or compound screenings to be carried out on a single millimetre-sized chip, such as LabChip Systems by Perkin Elmer or Diagnostic Chips Immunoassay LOC.  It is expected that this systems will become more powerful and able to detect more conditions as the technology advances further.

Bioinformatics, Gene Sequencing & Personalized Medicine

(Source)
As computing power increases and standard computing costs decrease, there will be a shift towards more data availability and subsequent analysis of huge data sets.  The National Center for Biotechnology Information’s (NCBI) GenBank database has become one of the most important tools for all biological researchers and contains over 150 billion nucleotide bases, which is continuing to grow exponentially, doubling every 10 months. This provides researchers with more information at a higher, population level allowing them to have a more comprehensive picture of normal versus diseased states enabling identification of more genetic or epigenetic based diseases.  A general shift towards having more electronically recorded medical records will also permit easier data sharing among researchers and clinicians providing the opportunity for new discoveries.

Additionally with the price of genomic sequencing falling and the speed at which sequences are being produced increasing, the availability of personal genomic sequence profiling is becoming closer to a reality than ever before. With improved uptake by the population and more sequences being added to databases for analysis, a more detailed and precise a picture of each individual’s state will become possible enabling much more personalized medicine.  Developments in personalized medicine will allow for better diagnosis, improved safety of prescribed drugs and more efficacious treatments. Current research into pharmacogenetics is expected to vastly change the pharmaceutical industry to provide personally tailored medications based on an individual’s genetic profile and reduce harmful side-effects.  While there is still much research to done, the field is growing strongly and there is a high acceptance for more personalized medicine among patients.

Bioremediation, Bioreactors & Biofuels

(Bioreactors)
While it has long been known that microorganisms play a crucial role in degradation of waste material it is only recently that scientists began utilizing them for eliminating contaminants and pollutants from the environment.  This intensification is the result of our improved awareness of the impact that pollutants have on our environment and subsequently our health and the health of the planet.  A variety of microorganisms from bacteria to fungi have been identified that degrade and eliminate effluents from the environment and are being currently being used.  Recent research has also provided insights into the optimal conditions for specific organism’s metabolism of contaminants which will provide improved degradation.  Further research that is currently underway into optimization of conditions, identification of new remediating organisms, and genetic manipulation of existing organisms will provide great improvements in this process in the future.
(Algae Biofuel Production)

Another emerging application for biotechnology involving microorganisms is the creation of biofuels.  The use of algae as a biomass for biofuel generation has gained tremendous momentum in recent years as the realities and difficulties of using plant-based and agricultural by-products as biomass have become apparent.  Algal biofuel production has many advantages over plant-based biomass such as providing high yields in small areas, minimal impact on freshwater sources, and not using land typically used for food agriculture. Additionally, algal-based biofuels have higher returns on energy and release lower greenhouse gas emissions compared to conventional advanced biofuels such as cellulosic ethanol.  This has spurred it into the forefront as the primary biomass for the next generation of biofuels and advancements in this area are expected to drive it into the future. 

Wednesday, December 15, 2010

Why we started Invention Evaluator



By Dr. Michael Manion

Over the years I have had lots of people tell me that they have a great idea, but just didn’t know what to do next.   It can be difficult to take the next steps, especially when you are unsure of the process involved in getting it developed, protecting your intellectual property and figuring out how to commercialise it.  So most great ideas stay that way, just an idea.
That’s why we built http://www.inventionevaluator.com/.  We saw a lack of objective analysis and honest help available for people  to navigate their idea from their head to the marketplace. 
For $199 you submit your idea online at, www.InventionEvaluator.com and within ten business days, you will receive a thorough analysis of your idea in a comprehensive report.  The analysis  covers:
-          The technology: understanding what the invention is, how it works, and what further development needs to be done.
-          The intellectual property: understanding what rights might be available to you to protect your intellectual property and build a package.
-          The commercialisation: understanding the market(s) you might be able to access to commercialise your invention.
Perhaps the most important thing we offer in doing this is objectivity.  Everyone can do their own searches and information gathering, but in order to properly analyse an idea you need to be unbiased and honest.  
If you’ve had an idea kicking around in your head, check out our website and do something about it.  Maybe 2011 could be the year it becomes more than just an idea...